Background. Chronic kidney disease due to diabetes (DCKD) is the main known cause of renal replacement therapy (RRT) initiation. A Centers for Disease Control and Prevention study showed that the rate of DCKD cases initiating RRT among the overall DM population has dropped in the USA. Our main objective was to analyse this rate in Catalonia in 1994 , 2006 in the diabetic population and characteristics and survival of DCKD patients on RRT were also evaluated. Methods. Data from the Catalan Renal Registry was used to learn the number of DCKD cases on RRT together with their characteristics and survival rates. Data from the Catalonia Health Survey established the diabetic population and also the prevalence of CVRF in this population. Results. The adjusted rate (95% CI) of patients initiating RRT with DCKD was 509
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Background. Chronic kidney disease due to diabetes (DCKD) is the main known cause of renal replacement therapy (RRT) initiation. A Centers for Disease Control and Prevention study showed that the rate of DCKD cases initiating RRT among the overall DM population has dropped in the USA. Our main objective was to analyse this rate in Catalonia in 1994, 2002, 2006 and 2010. Cardiovascular risk factors (CVRF) in the diabetic population and characteristics and survival of DCKD patients on RRT were also evaluated. Methods. Data from the Catalan Renal Registry was used to learn the number of DCKD cases on RRT together with their characteristics and survival rates. Data from the Catalonia Health Survey established the diabetic population and also the prevalence of CVRF in this population. Results. The adjusted rate (95% CI) of patients initiating RRT with DCKD was 509.1 (484.6-533. 7 Conclusions. Since 2002, the rates of patients with DCKD initiating RRT among the overall DM population decreased slightly in Catalonia. Survival in these cases has increased progressively and in 2006 is similar to the CKD patients due to other causes. This figure suggests a better overall management, especially of CVRF.
Catalonia, and in 2010 was responsible for 217 new cases (23% of cases) [3] . According to the European Renal AssociationEuropean Dialysis and Transplant Association (ERA-EDTA) registry report of 2010 [4] , in Spain, this percentage ranged between 16 .6% in the Basque Country and 32.9% in Extremadura. The exception was the Canary Islands which stood out from the rest of the communities with 46.5% of new patients. Among European countries, the ones with the highest incidence of DCKD were Finland (34.6%), Austria (30.1%) and Greece (29.2%), while countries with the lowest percentages were the Netherlands (14.1%), Romania (14.2%) and Iceland (15.2%). At a worldwide level, Malaysia (58%), Mexico (58%) and Thailand (48%) presented the highest percentages of incident patients with DCKD on RRT [5, 6] .
Although DCKD is the main cause of RRT initiation in most countries, among prevalent cases, DM as a primary renal disease (PRD) is no longer the most frequent cause. In Catalonia, the percentage of DCKD among prevalent patients was 13.3% [3] , in the Basque Country 10.0%, in Extremadura 13.9% and in the Canary Islands 34.0%. In Europe, the percentage of DCKD among prevalent patients was as follows: in Finland 25.8%, Austria 21.1% Greece 18.6%, the Netherlands 6.9%, Romania 9.9% and Iceland 8.4% [4] . The difference between incidence and prevalence is due to the fact that DCKD is the PRD with the highest mortality rates. Between 2005 and 2010, the mortality rate in patients with DCKD on RRT in Catalonia was 16.2 per 100 person/year, followed by vascular nephropathy (13.7 per 100 person/year) and unknown PRD (10.8 per 100 person/year) [3] .
Given the clinical, social and economic consequences of DCKD, to prevent its appearance and progression has always been a primary target of healthcare services [7] . Therefore, it is essential that in the care plan for diabetic patients, general practitioners, endocrinologists and nephrologists implement measures to achieve a good control of the main risk factors for DCKD, such as hyperglycaemia, proteinuria and hypertension. Tobacco use, as well as other associated comorbidities accompanying CKD, also need to be carefully evaluated and adequately managed.
A recent study performed by the Centers for Disease Control and Prevention (CDC) of the USA using data from the United States Renal Data System [8] showed that despite an increase in the number of DCKD cases initiating RRT, the rate of these patients, of the patients ≥ 18 years with diagnosed DM, dropped from 304.5 per 100 000 persons in 1996 to 199.1 per 100 000 persons in 2007. This reduction in the rate was observed in all US regions. These results can be attributed to a reduction in and a better control of the risk factors associated with end-stage renal disease (CKD stage 5) and improved management of CKD patients with new therapies.
The main objective of our study was to know the evolution of DCKD in Catalonia, analysing the rate of DCKD patients who started RRT in the years 1994, 2002, 2006 and 2010, out of the general DM population of Catalonia in those years. At the same time, for the 4 years studied, cardiovascular risk factors (CVRF) in the diabetic population were described and the characteristics and survival of DCKD patients on RRT were evaluated.
S U B J E C T S A N D M E T H O D S
The rates studied were calculated by dividing the number of cases initiating RRT due to DM in 1994 DM in , 2002 DM in , 2006 DM in and 2010 in Catalonia (A) by the number of prevalent DM cases in those years (B). The rates obtained were adjusted for age and sex using the direct method and the 95% confidence interval (95% CI) was calculated.
The A cases were obtained from the Catalan Renal Registry (RMRC) which is a mandatory population-based registry collecting information on all patients with end-stage renal disease (CKD stage 5), requiring RRT, either haemodialysis (HD), peritoneal dialysis or renal transplant (RT), in all centres of Catalonia. The RMRC gathers information about initiation of first RRT, changes of centre and/or treatment modality, deaths and patient exclusion, as well as annual follow-up of all active cases on the 31st of December of each year. We selected patients aged ≥15 years with CKD stage 5 initiating RRT for the first time due to DM in 1994, 2002, 2006 and 2010. The diagnosis of DCKD is specified by the clinician at the moment of notifying the case to the registry using ERA-EDTA PRD codes linked to the cause of patient entrance in RRT. These codes are 80 (for Type 1-DCKD) and 81 (Type 2-DCKD). We also selected patients initiating RRT due to secondary DM (our code 97).
For estimating the denominator (B), data from the Health Survey of Catalonia (ESCA) carried out since 1994 was utilized. This survey was developed as a result of the Health Plan of Catalonia 1993-1995, which proposes data collection on the state of health and use of health services by the Catalan population. The ESCA uses a representative population sample to perform a face-to-face interview. In this study, ESCA data corresponding to years 1994 [9], 2002 [10] , 2006 [11] and 2010 [12] was used. Whether DM was present or not was evaluated following a direct question about the presence or past presence of a series of health disturbances, including DM. The number of persons aged ≥15 years with DM in Catalonia (B) calculated at the ESCA, is an estimate using weighting factors which take into account the size of the territory and the age and sex of the sampling performed in the survey.
For the description of CVRF in the general diabetic population, we took into account the questions from each ESCA survey related to sex and age, presence of hypertension, the anti-hypertensive drugs, tobacco use and body mass index (BMI). Because of the fact that the data provided by the ESCA was aggregated by sex and age group (15-44, 45-64 and over 64 years), there are certain limitations regarding the description of these variables. Hence, the percentage of men over 45 years was calculated as a sex and age CVRF.
To describe the characteristics of DCKD patients on RRT, we used data from the RMRC. The following issues at the time of initiating RRT were studied: age, sex, type of DM, BMI, overweight (BMI ≥ 25 kg/m 2 ), degree of functional autonomy, first vascular access, type of initial RRT, cardiovascular comorbidity, presence of hypertension and situation with respect to the waiting list for RT. BMI, overweight, hypertension and first vascular access were not available for the first year of the study (1994), as they began to be collected by the RMRC later. For the evaluation of the degree of functional autonomy in RRT patients, the Karnofsky's scale, adapted by Gutman for patients on dialysis, was used [13] , with values 4 and 5 of this scale qualifying for special attention. The differences between each of the years studied were assessed using the χ 2 test for categorical variables and the analysis of variance for continuous variables.
To analyse patient survival of DCKD patients on RRT we also used data from RMRC and only considered the incident cases of 1994, 2002 and 2006. The cases initiating RRT in 2010 did not have sufficient follow-up time for a survival analysis to be performed, as information was only available until 31 December 2010. Likewise, survival of 2006 incident patients has only been followed up for 4 years. To calculate patient survival Kaplan-Meier analysis was performed and to evaluate differences between curves, the log-rank test was used. A Cox regression adjusted for age and gender was also carried out to evaluate the magnitude of difference in the risk of death between the years studied and the cause of RRT initiation (DM or other causes).
The statistical analysis was carried out using STATA software version 11.
R E S U LT S
Rate of patients initiating RRT with DCKD Table 1 shows the rate of patients initiating RRT due to DM, out of the general DM population of Catalonia, in the 4 years studied, together with the figures used for calculation according to ESCA and RMRC. After adjusting for age and sex the crude rates resulting from the division of incident cases on RRT with DCKD by the estimated DM population, we have obtained a rate of 509.1 (484. 6- 
Evolution of CVRF in the DM population of Catalonia
The percentage of males over 45 years in the DM population aged ≥15 years has increased over time from 38.1 to 48.3%. The cases with hypertension among these patients have increased from 37.0 to 59.6%. This increase was observed in both sexes, although women always presented a higher percentage than men. The use of anti-hypertensive drugs followed a similar growth pattern, although in men no increase was observed between 2006 and 2010. Overall, tobacco use in this population grew, but with different patterns according to sex. In men there was a drop in the percentage of smokers (from 28.7 to 20.1%) while in women there was an increase in its use (from 2.9 to 14.3%). The overweight factor was only available in 2006 and 2010 ESCA surveys. We observed an increase in the percentage of overweight patients, globally and in both sexes ( Table 2) . Table 3 shows the evolution of characteristics at the beginning of RRT in incident patients with DCKD in the 4 years studied. The percentage of cases with Type 1 DM declined throughout the years studied, although the absolute number remained stable.
Characteristics of patients with DCKD
The increase in the percentage of male patients was statistically significant (P = 0.02) and ranged from 51.3% in 1994 to 68.8% in 2010. The mean age (95% CI) of incident patients did not show statistically significant differences (P = 0.09), although there was a tendency towards a rise from 63.2 years in 1994 to 66.5 years in 2010. However, we found statistically significant differences by age group (P = 0.003). The group of 
O R I G I N A L A R T I C L E
E v o l u t i o n o f t h e i n c i d e n c e o f C K D patients over 75 years was the one which increased the most over time.
The initial type of RRT remained stable over time, with HD being the most frequently indicated initial treatment (between 88 and 94% of cases) followed by peritoneal dialysis (PD) (between 6 and 11% of cases) and finally pre-emptive RT (<1% of cases).
Cardiomyopathy or congestive heart failure and vascular disease were the most frequent cardiovascular co-morbidities (ranging from 38 to 49% of cases). During the years studied, only cerebrovascular disease showed statistically significant differences (P = 0.03), increasing from 12.6% in 1994 to 14.7% in 2010. Overall, we observed 73.1, 77.2, 76.6 and 71.1% of cases with at least one cardiovascular disease, in each of the 4 years studied.
The percentage of cases with hypertension oscillated between 90 and 93% without statistically significant differences during the years studied. Regarding functional autonomy, the percentage of cases requiring special attention fluctuated over the 4 years studied, ranging 13.0 and 20.4% without statistical significance.
The percentage of overweight patients (BMI ≥ 25 kg/m 2 ) increased significantly (P = 0.003) as did the mean of BMI (P = 0.01). These figures could not be calculated in 1994 as no data related to height and weight at initiation of RRT was available.
The percentage of internal arteriovenous fistulae (AVF) as an initial vascular access in patients starting RRT with HD (data unavailable in 1994) oscillated between 38.9 and 46.1%, without statistically significant differences among the 3 years.
At the beginning of RRT, DCKD patients included on the RT waiting list awaiting clinical studies or recovering from an illness or surgery (theoretically candidates for kidney transplant) increased significantly over time (P < 0.001). Conversely, patients definitively excluded from the waiting list due to age, associated co-morbidities, surgical difficulties or the patient's personal decision, decreased.
In Figure 1 incident RRT patient survival for the years 1994, 2002 and 2006 are shown. In the fourth year, the survival was 35.9, 40.9 and 59.9% for patients initiating RRT in 1994, 2002 and 2006, respectively. In the eighth year, survival was 6.9 and 17.6% in 1994 and 2002 incident patients (P < 0.001). After adjusting for age and gender, the risk (95% CI) of death of DCKD patients initiating RRT in 1994 and 2002 was 2.14 (1.61-2.84) and 1.57 (1.21-2.05) times higher than 2006.
When comparing survival of these patients with incident cases on RRT due to other causes than DM, we observed that differences in survival were reduced progressively. The survival rate in the fourth year went from 35.9% in 1994, 39.9% in 2002 and 59.9% in 2006 for DCKD cases, to 64.9% (P < 0.001), 58.3% (P < 0.001) and 65.9% (P = 0.07), respectively, for CKD cases due to other causes (Figure 2) . In 1994 and 2002, DCKD patients had a risk of death (95% CI) 2.21 (1.78-2.74) and 1.58 (1.32-1.89) times higher than patients initiating RRT for other causes after adjusting for age and gender. In 2006 the risk of death between these groups was 1.16 (0.91-1.47), and no statistically significant difference was observed. 
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O R I G I N A L A R T I C L E E v o l u t i o n o f t h e i n c i d e n c e o f C K D D I S C U S S I O N
In this study, we observed an important increase in the adjusted rate of patients initiating RRT with DCKD between 1994 and 2002. This fact can be explained by changes in dialysis entry criteria, which became more liberal during these years due to advances in and more widespread availability of dialysis technology which allowed diabetics and older patients to receive this treatment. These advances led to an increase in the number of patients initiating RRT with DCKD, from 119 in 1994 to 203 in 2002. Earlier and more accurate diagnosis of DM and DCKD in the general population, introduced by the consensus documents and clinical practice recommendations since 1997 [14] , probably also influenced this increase in incident DCKD patients. Since 2002 onwards, the tendency towards an increase in patients with DCKD initiating RRT among the overall DM population has decreased slightly in Catalonia, as has been previously observed in the USA [8, 15] . Using the same RRT inclusion criteria, there was a decrease of 7% in the adjusted rate, which fell from 645.3 pmp in 2002 to 600.0 pmp in 2010. This is a promising result from the perspective of healthcare targets, which suggests that the great coordinated effort made by the professionals involved in DM management in general, and diabetic nephropathy in particular, have been worthwhile. The results of a study carried out by a Spanish group [16] shows a decline in this rate in the Spanish Autonomous Communities of Extremadura, Asturias, Castile Leon, Galicia and Cantabria, and an increase in the Basque Country, Andalusia, Valencia, Castile La Mancha, Navarra and the Canary Islands.
The results of our study do not permit us to specify which factors are implicated in this improvement. However, it is probably related to earlier diagnosis and better management of diabetes and diabetic nephropathy, based on the multidisciplinary approach of the different professionals involved [17] . This allows for earlier and better control of CKD progression risk factors, as well as the widespread utilization of renin-angiotensin system blockers which have been demonstrated to provide nephroprotection in this setting. Nevertheless, the increase in the prevalence of the different CVRF in the Catalan diabetic population, which can be partially explained by more stringent criteria in hypertension diagnosis, should continue to hold our attention. To prevent CKD associated with DM, the promotion of a healthy lifestyle and better control of cardiovascular and renal risk factors is mandatory.
Once on RRT, the profile of the patient with DCKD has moved towards older and more overweight patients, as occurs in the general DM population, and with a high prevalence of hypertension (90% of cases). Faced with this situation, it is worth observing that while survival in incident cases on RRT due to other causes than DM barely changed between 1994 and 2006, the survival in incident DCKD patients on RRT, which was worse in 1994 and 2002, has progressively improved. This reached a point where no significant differences between these two groups were observed in 2006. This figure also suggests better management of CVRF and other CKD co-morbidities in DCKD patients. In fact, cardiovascular disease is the main cause of death in RRT [3] . The greater access to the waiting list for RT shown in this study could also be linked to the increase in number of RT in DCKD patients, and the consequent improvement of their survival, from 8.1% of overall RTs in 1994-1998 to 11.6% in the 2004-2008 [3] .
Our study has several limitations, and as with the CDC study, we cannot determine whether or not there were greater numbers of patients dying before initiating RRT. However, according to the last Health Department mortality report of the Generalitat of Catalonia, mortality due to endocrinological causes has remained stable in recent years (∼20 deaths per 100 000 inhabitants) [18] . Another limitation observed is the increase in the percentage of patients communicated to RMRC with a CKD due to unknown causes (20.2% in 1994, 21 .3% in 2002, 25.9% in 2006 and 28.0% in 2010). Among these cases, there may be patients with DCKD not as such, although the notification criteria have not been modified during the years of the study. For further studies, the addition of incident cases with other PRD and a DM as a comorbidity could partially correct this classification bias as Villar and colleagues propose [19] .
The increase in immigration rates in Catalonia could also affect the results. There was an increase in immigrant population in Catalonia from 5.9% in 2002, to 12.8% in 2006 and 15.9% in 2010 [20] , and it is known that within the immigrant population, the diagnosis of DM takes place at an earlier age [21] . However, in the DM population, according to ESCA data, the percentage of immigrants in this population was 2.3% in 2002, 2.9% in 2006 and 5.8% in 2010, which means that the reduction observed in the rate of DM patients initiating RRT between 2002 and 2006 does not coincide with an increase in the immigrant diabetic population.
In conclusion, this study has two positive messages, despite the fact that DM is still the main known cause of CKD stage 5 and RRT initiation in Catalonia, a tendency towards a slight decrease in DM patient rates progressing to CKD stage 5 has been observed since 2002. This situation is the result of the slowdown in DCKD progression among the growing DM population, which is a crucial aspect of the effort to reduce the morbidity, mortality and economic burden of this population. At the same time, there is an improvement in the survival of these patients, progressively approaching that of CKD patients on RRT due to other causes. This situation surely reflects that earlier application of preventive measures and treatment, as well as multidisciplinary management of the diabetic patient, implementation of guidelines, and access to renal transplantation over time have impacted positively on patients' outcomes.
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